Robert Owen Lockerbie

Title: The Innovations of Robert Owen Lockerbie

Introduction

Robert Owen Lockerbie is a notable inventor based in Littleton, Colorado. He has made significant contributions to the field of biotechnology, particularly in the area of pathogen management in blood components. With a total of two patents to his name, Lockerbie's work has the potential to impact medical practices significantly.

Latest Patents

Lockerbie's latest patents focus on the induction and maintenance of nucleic acid damage in pathogens using riboflavin and light. This innovative process involves adding an effective amount of riboflavin to blood or blood components containing pathogens, such as white blood cells, bacteria, and viruses. The fluid is then exposed to light of an appropriate wavelength to damage the nucleic acids of the pathogens. This method not only damages the nucleic acids but also maintains that damage, allowing for subsequent transfusion into a recipient.

Career Highlights

Robert Owen Lockerbie is currently associated with Caridianbct Biotechnologies, LLC, where he continues to develop and refine his innovative processes. His work is crucial in enhancing the safety and efficacy of blood transfusions, which can save countless lives.

Collaborations

Lockerbie has collaborated with notable colleagues, including Vijay Kumar and Shawn D Keil. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert Owen Lockerbie's contributions to biotechnology through his innovative patents demonstrate his commitment to improving medical practices. His work in pathogen management is paving the way for safer blood transfusions and has the potential to make a significant impact in the healthcare industry.